Alector, Inc.

US$2.29As of Sun 8 Nov 2026, 12:00 UTC
NASDAQ:ALECHealthcare
Country USA
PE (Fwd) •••
TSR 8Y CAGR (24.35%)
Div yield —
ROE 47.52%
Biotechnology
Beta (5Y) 0.61
PE TTM 6.177
TSR TTM 55.78%
Mkt cap US$340.9M
ROIC 20.31%
SE Grade™
Value
Quality
Moat
Consensus
Reference
$2.72
18.98%
(54.36%)
Hold 7|10|9|9|8
4Q25
1Q26
2Q26
3Q26
Earnings per share$
0.03
0.03
0.03
0.03
44.49%
37.89%
40.02%
27.26%
Revenue$M
15.94
16.63
17.56
18.07
2.39%
6.87%
7.05%
12.19%
Peers (US$340.9M)
Cap (US$)
PE
344.6M
—
341.1M
—
Capital
TTM
5Y
10Y
Leveragex
1.102
0.046
0.046
EBIT/Intx
1.683
1.872
2.023
Own earn%
(18.00)
76.02
76.27
Sh yield%
29.52
45.04
41.41
Owners
Insiders/Inst%
2.84
71.04
Short interest%
1.23
SBC / revenue%
5.82
Record
10Y
Profitable years
10/10
Revenue growth years
10/10
EPS growth years
10/10
Dividend streakyrs
3
Op margin range%
22–26
$1 testx
—
Incr. ROIC%
6